Is it safe to get Topamax online?

If you’re struggling with binge eating disorder (BED), you’ve probably wondered whether you can access treatment through telehealth—especially if traditional in-person appointments feel difficult to schedule or overwhelming to attend. The short answer is yes: legitimate telehealth providers can legally prescribe medications for binge eating disorder in all 50 states, and you typically don’t need an in-person visit to get started.

This comprehensive guide will walk you through everything you need to know about accessing BED treatment online, including which medications are available, how telehealth prescribing works, state-specific rules, and what to expect from a quality telehealth provider.

Understanding Binge Eating Disorder and Treatment Options

Binge eating disorder is the most common eating disorder in the United States. It’s characterized by recurrent episodes of eating large quantities of food in a discrete period (typically within two hours), accompanied by a sense of loss of control. To meet diagnostic criteria, these episodes must occur at least once weekly for three months and cause significant distress.

Unlike bulimia nervosa, BED doesn’t involve compensatory behaviors like purging or excessive exercise. Many people with BED struggle in silence, feeling ashamed or believing their eating patterns are simply a ‘willpower problem’ rather than a treatable medical condition.

Evidence-based treatment for BED typically includes:

• Psychotherapy: Cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT) have strong research support
• Nutrition counseling: Working with registered dietitians who specialize in eating disorders
• Medication: Off-label use of certain medications that can reduce binge frequency and address underlying symptoms
• Support groups: Peer support through organizations like Overeaters Anonymous or NEDA

While therapy remains the gold standard treatment, medication can be a valuable component of comprehensive care—particularly when combined with therapeutic support.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Medications Commonly Prescribed for Binge Eating Disorder via Telehealth

Topiramate (Topamax)

What it is: Topiramate is an anticonvulsant medication FDA-approved for seizure disorders and migraine prevention. Research suggests it may help reduce binge eating episodes and support weight management when used off-label for BED.

How it works for BED: While the exact mechanism isn’t fully understood, topiramate appears to affect neurotransmitters involved in appetite regulation and impulse control. Studies have shown it can reduce binge frequency and promote modest weight loss in some patients.

Typical dosing: Providers usually start with a low dose (25mg) and gradually increase over several weeks to minimize side effects. The target dose for BED typically ranges from 75-200mg daily.

Important safety considerations:

• Pregnancy risk: Topiramate is associated with increased risk of cleft palate and other birth defects. Women of childbearing potential should use effective contraception
• Cognitive effects: Some patients experience ‘brain fog,’ word-finding difficulties, or concentration problems
• Gradual tapering required: Don’t stop abruptly—seizure risk increases with sudden discontinuation
• Monitoring needs: Regular check-ins for weight, metabolic effects, and cognitive side effects

Bupropion (Wellbutrin)

What it is: Bupropion is an antidepressant FDA-approved for depression and smoking cessation. It’s used off-label for BED, particularly when depression or emotional eating contributes to binge episodes.

How it works for BED: Bupropion affects dopamine and norepinephrine—neurotransmitters involved in mood, motivation, and reward processing. By addressing underlying depression and potentially reducing reward-driven eating, it may help some people decrease binge frequency.

Typical dosing: Starting dose is usually 150mg daily, potentially increasing to 300mg extended-release depending on response and tolerability.

Important safety considerations:

• Seizure risk: Bupropion lowers seizure threshold and is contraindicated in anyone with a current or past eating disorder involving purging (bulimia or anorexia nervosa), as malnutrition and electrolyte imbalances increase seizure risk
• Black box warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in people under 25. Close monitoring is essential, especially when starting treatment
• Avoid alcohol: Combining bupropion with alcohol significantly increases seizure risk
• Monitoring needs: Regular mood checks, blood pressure monitoring (it can raise BP slightly), and assessment of any seizure risk factors

Important note: Both medications are used off-label for BED. While only Vyvanse (lisdexamfetamine) is FDA-approved specifically for moderate-to-severe BED, that medication is a controlled stimulant with stricter telehealth prescribing limitations. Off-label use of topiramate and bupropion is legal, common, and supported by clinical research—your provider should discuss the evidence and obtain your informed consent.

Federal Telehealth Prescribing Rules: What You Need to Know

Understanding the federal landscape helps clarify why these medications are accessible via telehealth while others (like controlled substances) face more restrictions.

The Ryan Haight Act and Non-Controlled Medications

The Ryan Haight Online Pharmacy Consumer Protection Act (2008) regulates telehealth prescribing of controlled substances—medications with abuse potential that the DEA schedules as controlled (like opioids, benzodiazepines, and stimulants).

Here’s the critical point: Topiramate and bupropion are not controlled substances. They’re classified as ‘legend drugs’ (prescription-only) but fall outside the Ryan Haight Act’s scope entirely.

This means:

• No federal in-person requirement exists for these medications
• No special DEA registration required for providers prescribing them via telehealth
• Standard prescribing rules apply—the same as any prescription medication

The temporary telehealth flexibilities you’ve heard about regarding controlled substances (extended through December 31, 2026) don’t even apply here because these BED medications were never restricted in the first place.

Current DEA Telehealth Policy (for context)

While it doesn’t affect the medications discussed here, it’s worth understanding the broader landscape:

• COVID-era flexibility: During the pandemic, the DEA allowed providers to prescribe controlled substances via telehealth without an initial in-person visit
• Current status: This flexibility has been extended four times and currently runs through December 31, 2026
• Pending permanent rules: The DEA is working on permanent telehealth prescribing regulations (expected by end of 2026)
• Impact on BED treatment: These rules primarily affect stimulant medications like Vyvanse. Most legitimate telehealth platforms don’t prescribe controlled stimulants for BED due to safety and regulatory concerns, focusing instead on the non-controlled options we’re discussing

Bottom line: For topiramate and bupropion, federal law poses no special barriers to telehealth prescribing. The rules that do apply are the same standard-of-care requirements that govern all medical practice.

State-by-State Telehealth Rules: Where Can You Get Treatment?

While federal law is permissive for non-controlled medications, individual states set their own telehealth practice standards. The good news: all states allow telehealth prescribing of non-controlled medications when done appropriately.

States with No In-Person Requirement

These states allow you to start and continue BED medication treatment entirely via telehealth:

California: Among the most progressive telehealth states. A 2025 law (AB 1503) explicitly defined ‘good faith prior examination’ to include asynchronous telehealth evaluations for non-controlled medications. Providers must meet the appropriate standard of care, but that standard can be satisfied entirely through telehealth—even using online questionnaires and video consultations.

New York: No state in-person requirement for non-controlled medications. (Note: New York adopted a May 2025 rule requiring in-person exams before prescribing controlled substances once federal waivers end, but this doesn’t affect Topamax or Wellbutrin.)

Texas: Allows telehealth prescribing of non-controlled medications without in-person visits. Texas restricts teleprescribing of certain Schedule II controlled substances for chronic pain, but mental health and general medical prescribing (including BED treatment) can occur fully via video visits.

Florida: No in-person requirement for non-controlled prescriptions. Florida prohibits teleprescribing most Schedule II drugs without prior in-person evaluation, but this doesn’t impact BED medications.

Delaware: State telehealth law permits fully remote prescribing for non-controlled medications. A July 2025 amendment (SB 101) clarified that medication-assisted treatment for opioid use disorder can occur via telemedicine, further reinforcing the state’s commitment to telehealth access.

Michigan: No specific in-person requirement. Michigan’s 2023 legislation expanding nurse practitioner practice authority (effective 2025) also reaffirmed telehealth standards that align with federal flexibility.

Wisconsin: Allows telehealth prescribing when standard of care is met, with no mandated in-person visit for these medications. Wisconsin’s August 2025 APRN Modernization Act enhanced access by granting nurse practitioners full practice authority.

South Carolina: State regulations specify that an ‘appropriate evaluation’ is required, which explicitly need not be in-person if adequate information can be obtained via telehealth. The state medical board has codified that telemedicine exams meeting the standard of care satisfy prescribing requirements.

States Requiring Periodic In-Person Follow-Up

A few states require an in-person visit within a certain timeframe for ongoing telehealth care:

Alabama: If a patient receives more than four telehealth visits within 12 months for the same condition, the provider (or a collaborating provider at the practice) must see the patient in person within that 12-month period. For starting BED treatment, you can begin entirely via telehealth; the periodic in-person requirement applies only to longer-term care.

Georgia: Requires providers to attempt to see patients in person at least annually for ongoing telemedicine care. Initial evaluation can occur via telehealth if it’s equivalent to an in-person exam (using appropriate technology and meeting standard-of-care requirements). The annual in-person visit can be satisfied by any collaborating provider in the practice.

New Hampshire: A 2025 law (SB 252, effective August 2025) modernized telehealth prescribing rules. For controlled substances (Schedule II-IV), New Hampshire now allows initial telehealth prescribing but requires an in-person follow-up within 12 months. For non-controlled medications like those used for BED, this requirement doesn’t technically apply, though providers may adopt similar follow-up practices for continuity of care.

Important note: Even in states with periodic in-person requirements, these rules are designed to ensure continuity and safety—not to create barriers. The in-person visit can often be with any qualified provider at the practice (not necessarily your telehealth prescriber), and many telehealth platforms partner with local clinics to facilitate these visits when needed.

Provider Licensing: You Must Be Treated by Someone Licensed in Your State

This is a critical rule that applies in all states: Your telehealth provider must hold an active medical license in the state where you’re physically located during the appointment.

Why this matters:

• A California-licensed doctor can treat you via telehealth only if you’re in California during the visit
• Most telehealth platforms verify your location and match you with appropriately licensed providers
• Interstate medical licensure compacts (like the Interstate Medical Licensure Compact) make it easier for providers to obtain licenses in multiple states, expanding access

What to verify:

• Ask which states the telehealth service covers
• Confirm your provider is licensed in your state (reputable platforms display this information)
• Understand that traveling to another state may affect your ability to receive care from your usual telehealth provider

Who Can Prescribe BED Medications via Telehealth?

Physicians (MDs and DOs)

All medical doctors and doctors of osteopathy licensed in your state can prescribe topiramate and bupropion for BED via telehealth, subject to the state rules outlined above.

Nurse Practitioners (NPs)

The landscape for nurse practitioner prescribing authority has evolved significantly. As of 2025, approximately 34 states plus Washington, D.C. grant nurse practitioners full practice authority—meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.

States with NP full practice authority include:

• Alaska, Arizona, Arkansas, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, Wyoming
• Recently added (2023-2025): Louisiana, Kansas, Wisconsin, Michigan

In these states, an NP can provide your entire BED evaluation and treatment independently via telehealth.

States with collaborative/supervisory requirements:In states like Alabama, California (with caveats—California grants FPA after 3 years of experience), Florida, Georgia, South Carolina, and Texas, nurse practitioners must work under a collaborative agreement with a physician to prescribe medications.

What this means for you:

• Your NP can still prescribe Topamax or Wellbutrin for BED in these states
• There’s a supervising physician connected to your care (often behind the scenes)
• This arrangement doesn’t usually affect your patient experience—you’ll still primarily interact with the NP
• Both the NP and collaborating physician’s names may appear on documentation

Physician Assistants (PAs)

Physician assistants can prescribe non-controlled medications in all states under physician supervision. The specific scope varies by state, but PAs working with telehealth platforms can prescribe BED medications in collaborative practice arrangements.

Key takeaway: Whether you see an MD, DO, NP, or PA via telehealth, you can receive appropriate BED medication management as long as the provider is licensed in your state and follows applicable collaborative practice requirements.

What to Expect from a Quality Telehealth BED Evaluation

Initial Assessment Process

A thorough telehealth evaluation for BED should take at least 30-45 minutes for the initial appointment. Be wary of any service that promises prescriptions after a brief questionnaire.

Your provider should:

1. Verify your identity and location

• Confirm you’re in a state where they’re licensed
• Document your physical address for medical records
• This is required by many state regulations and prevents fraud

2. Conduct a comprehensive clinical interview

• Eating behavior history: Detailed questions about binge episodes, frequency, triggers, foods involved, and associated feelings
• DSM-5 criteria assessment: Confirming you meet diagnostic criteria (recurrent binge episodes with loss of control, occurring at least weekly for 3+ months, without regular compensatory behaviors)
• Mental health screening: Depression, anxiety, trauma history, and other psychiatric conditions
• Medical history: Previous eating disorder treatment, other medical conditions, current medications, allergies
• Social history: Living situation, support system, work/school stress, relationship with food and body image

3. Rule out contraindications

• For bupropion: History of seizures, eating disorders with purging (bulimia/anorexia), current alcohol/sedative use
• For topiramate: Pregnancy or planning pregnancy, kidney stones, glaucoma, metabolic acidosis
• Review medication interactions with your current prescriptions

4. Discuss treatment options

• Explain why a particular medication is recommended
• Review the evidence for off-label use in BED
• Discuss expected benefits, potential side effects, and timeline
• Present alternatives (therapy options, other medications, combination approaches)

5. Obtain informed consent

• Document that you understand off-label use
• Confirm you’ve discussed risks and benefits
• Ensure you have opportunities to ask questions

6. Create a treatment plan

• Medication dosing and titration schedule
• Follow-up appointment schedule
• Warning signs to watch for
• Instructions for when to seek urgent care
• Referrals to therapy or nutrition support (comprehensive BED treatment should be multidisciplinary)

Red Flags: Signs of Questionable Telehealth Practices

Be cautious if a telehealth provider:

• Promises medication before evaluation: Legitimate providers don’t guarantee prescriptions—they evaluate first
• Rushes through the assessment: A 5-10 minute questionnaire isn’t sufficient for BED diagnosis
• Doesn’t discuss therapy or lifestyle interventions: Medication alone rarely addresses BED; ethical providers present comprehensive options
• Skips contraindication screening: Not asking about pregnancy, seizure history, or other medications is dangerous
• Ships medication directly without using a pharmacy: Legitimate prescriptions go through licensed pharmacies
• Doesn’t verify your location or identity: State licensing laws require this
• Pressures you toward expensive out-of-pocket programs: While some services are cash-pay, ethical providers respect your insurance options and budget

What good telehealth looks like:

• Thorough, unhurried evaluation
• Transparent about what’s FDA-approved versus off-label
• Discusses non-medication options
• Provides clear safety information
• Schedules appropriate follow-up
• Sends prescriptions to your choice of pharmacy
• Offers ways to reach the care team between visits

Prescription Monitoring and Safety Checks

Prescription Drug Monitoring Programs (PDMPs)

Most states maintain prescription drug monitoring programs that track controlled substance prescriptions. For topiramate and bupropion, PDMP checks are generally not required by law because they’re not controlled substances.

However, responsible telehealth providers may still review your medication history as part of due diligence:

• Checking for potential drug interactions
• Ensuring you’re not receiving duplicate prescriptions
• Identifying any controlled substances that might interact or indicate other treatment needs

This is considered good clinical practice, even when not legally mandated.

Baseline and Ongoing Monitoring

Before starting medication, your provider may request:

• Recent lab work (metabolic panel, liver function, kidney function)
• Pregnancy test if applicable
• Weight and vital signs (blood pressure, heart rate)
• Baseline cognitive assessment for topiramate

During treatment, expect:

• Week 2-4 check-in: Assess tolerability, address side effects, begin titration
• Monthly follow-ups (initially): Monitor effectiveness, adjust dose, review symptoms
• Quarterly or biannual visits (once stable): Ongoing assessment, medication management, holistic care review
• Messaging access: Ability to report concerns between scheduled visits

Some telehealth platforms offer asynchronous messaging with nurses or care coordinators, while others use secure patient portals. Quality services provide clear escalation pathways for urgent issues.

Insurance Coverage and Cost Considerations

Telehealth Coverage

Most insurance plans now cover telehealth visits at the same rate as in-person appointments, a change accelerated by the pandemic that has largely become permanent. However, coverage specifics vary:

Medicare: Covers telehealth for mental health and some primary care services. BED treatment may be covered if provided by an eligible provider.

Medicaid: Coverage varies by state. Many states expanded telehealth coverage during COVID and maintained those expansions.

Private insurance: Most plans cover telehealth mental health and medical visits. Check your specific plan’s telehealth policy.

Klarity Health accepts both insurance and cash pay, offering transparent pricing and working with patients to find the most affordable option. Our platform verifies insurance eligibility upfront, so you’ll know your costs before your first appointment.

Medication Costs

Topiramate (generic):

• Without insurance: $10-30/month typically
• With insurance: Often $0-10 copay (generic tier)
• GoodRx or similar discount programs available

Bupropion (generic):

• Without insurance: $10-40/month typically
• With insurance: Usually generic tier copay ($0-15)
• Extended-release formulations may cost slightly more

Both medications are available as generics, making them affordable options compared to some newer eating disorder treatments.

Who Should (and Shouldn’t) Pursue Telehealth BED Treatment

Good Candidates for Telehealth BED Treatment

You’re likely a good fit for telehealth medication management if you:

• Meet DSM-5 criteria for binge eating disorder
• Have tried therapy or want to combine medication with ongoing therapeutic support
• Don’t have medical contraindications to the medications
• Have stable housing and reliable internet/phone access
• Can engage in video visits and follow-up care
• Live in a state where telehealth services are available
• Prefer the convenience and reduced stigma of receiving care at home
• Have difficulty accessing in-person eating disorder specialists in your area

When In-Person Care May Be More Appropriate

Telehealth may not be suitable if you:

Have certain medical contraindications:

• Active bulimia nervosa or anorexia nervosa (bupropion contraindicated)
• Uncontrolled epilepsy or seizure disorder
• Currently pregnant or breastfeeding without specialist oversight
• Severe medical instability requiring physical examination

Need more intensive treatment:

• Suicidal ideation requiring urgent psychiatric evaluation
• Severe malnutrition or medical complications from eating disorder
• History of multiple medication failures suggesting need for specialist care
• Concurrent severe substance use disorder

Face practical barriers:

• No reliable way to attend video appointments privately
• Inability to pick up prescriptions from a pharmacy
• Need for services requiring in-person evaluation (such as controlled stimulant medications)

A reputable telehealth provider will screen for these factors and refer you to appropriate in-person care when necessary. This isn’t a limitation—it’s responsible medicine.

How Klarity Health Makes BED Treatment Accessible

At Klarity Health, we’ve designed our telehealth platform to remove common barriers to eating disorder treatment while maintaining the highest clinical standards.

What sets Klarity apart:

Provider availability: We connect you with licensed psychiatrists and nurse practitioners who specialize in eating disorders and can typically schedule appointments within days, not months.

Transparent pricing: You’ll know your costs upfront. We accept most major insurance plans and offer clear self-pay rates with no surprise bills.

Flexible payment options: Whether you use insurance or prefer to pay out-of-pocket, we work with your situation. Our insurance verification team helps you understand your coverage before your first visit.

Comprehensive care approach: While we can prescribe medication when appropriate, our providers emphasize a holistic treatment plan. We’ll discuss therapy options, provide nutrition guidance resources, and coordinate with your existing care team.

Ongoing support: You’re not just getting a prescription—you’re getting a care team. Regular check-ins, medication management, and accessible messaging keep you supported throughout your treatment journey.

Privacy and convenience: Receive care from the comfort of your home, reducing the anxiety and time burden of traditional appointments. Our HIPAA-compliant platform protects your privacy.

Taking the First Step: What Happens Next

Getting Started with Telehealth BED Treatment

1. Choose a reputable telehealth platformResearch providers in your state. Look for services that:

• Employ licensed, credentialed providers
• Are transparent about costs and insurance
• Have positive patient reviews
• Offer comprehensive mental health services (not just prescriptions)

2. Complete an intake assessmentMost platforms have you fill out a health questionnaire covering:

• Your eating behavior and BED symptoms
• Medical and psychiatric history
• Current medications and allergies
• Treatment goals and preferences

3. Schedule your initial evaluationYou’ll meet with a provider (MD, DO, NP, or PA) via secure video visit. Block out at least 45-60 minutes for this appointment.

4. Collaborate on a treatment planYour provider will discuss medication options, expected timeline, and complementary treatments. You’ll decide together whether medication is right for you.

5. Start medication (if appropriate)Your prescription will be sent electronically to your pharmacy of choice. Start with the prescribed dose and follow titration instructions carefully.

6. Attend follow-up appointmentsRegular check-ins ensure the medication is working, side effects are manageable, and you’re progressing toward your goals.

7. Engage in additional supportConsider adding therapy (CBT or DBT), working with a registered dietitian, or joining a support group for comprehensive recovery.

What to Prepare for Your First Appointment

Gather this information beforehand:

• Current medication list (prescription and over-the-counter)
• Medical history summary (major illnesses, surgeries, chronic conditions)
• Mental health treatment history (previous diagnoses, medications tried, therapy)
• Recent lab work if available
• Insurance card if using insurance

Prepare to discuss:

• Specific examples of binge eating episodes
• Frequency and triggers
• How BED affects your daily life and well-being
• What you’ve tried previously (therapy, diets, other medications)
• Your treatment goals

Create a private, quiet space for your appointment:

• Good internet connection
• Comfortable, private setting where you can speak freely
• Charged device (phone, tablet, or computer with webcam)

The Future of Telehealth BED Treatment

The regulatory landscape for telehealth continues to evolve, generally in a direction that expands access while ensuring patient safety.

Trends to watch:

Permanent telehealth flexibilities: Many pandemic-era telehealth expansions are being codified into permanent law at both federal and state levels. This creates a stable foundation for continued telehealth access.

Expanded scope for nurse practitioners: More states are granting NPs full practice authority, increasing the supply of qualified providers who can deliver BED treatment via telehealth independently.

Interstate licensure compacts: Efforts to streamline provider licensing across state lines may eventually make it easier to receive care from out-of-state specialists.

Integration with therapy platforms: Increasingly, telehealth services are combining medication management with therapy sessions and other supports in one platform, making comprehensive BED treatment more accessible.

Quality standards and oversight: As telehealth matures, industry standards and regulatory oversight are improving, helping patients identify high-quality providers and avoid questionable operations.

Research on effectiveness: Ongoing studies continue to evaluate telehealth outcomes for eating disorders, with early evidence suggesting comparable or even superior outcomes compared to traditional care in many cases—likely due to reduced barriers and increased engagement.

Conclusion: Accessible, Legal, and Effective Care Is Here

If you’re struggling with binge eating disorder, telehealth offers a legitimate, convenient, and effective pathway to treatment. Medications like topiramate and bupropion can be prescribed safely via video visits in all 50 states, with no federal requirement for in-person exams before starting treatment.

The regulatory framework supporting telehealth has matured significantly since the pandemic. While rules vary slightly by state, the overall trend is toward expanded access with appropriate safety guardrails. Non-controlled medications used for BED face minimal restrictions, making them among the most accessible prescription treatments available via telemedicine.

Quality matters. Choose providers who conduct thorough evaluations, discuss comprehensive treatment options, maintain appropriate follow-up care, and practice transparently. Avoid services that feel like ‘pill mills’ or make prescribing decisions before adequate assessment.

Remember that medication is just one tool in BED recovery. The most effective treatment combines medication (when appropriate) with evidence-based therapy, nutritional support, and lifestyle changes. A good telehealth provider will emphasize this comprehensive approach and connect you with additional resources.

You deserve accessible, judgment-free, evidence-based care. If traditional in-person appointments feel overwhelming or aren’t available in your area, telehealth can bridge that gap—connecting you with specialized providers who understand eating disorders and can offer the treatment you need.

At Klarity Health, we’re committed to making mental health care, including BED treatment, accessible to everyone. Our board-certified providers offer compassionate, expert care through convenient telehealth visits. With transparent pricing, insurance acceptance, and a focus on comprehensive treatment, we’re here to support your journey toward recovery.

Ready to take the next step? Schedule a consultation with Klarity Health today to discuss whether telehealth BED treatment is right for you. Recovery is possible, and you don’t have to face it alone.

References

1. U.S. Department of Health & Human Services. (2026, January). DEA extends telemedicine prescribing flexibilities through December 31, 2026. HHS.gov. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Sheppard Health Law. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025). Online prescribing state laws. CCHP Telehealth Policy Database. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (updated 2025). https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. DailyMed, National Library of Medicine. Bupropion hydrochloride extended-release tablets prescribing information. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

📅 RESEARCH CURRENCY STATEMENT
Verified as of: January 4, 2026

This article reflects telehealth prescribing regulations and clinical guidance current through January 2026. Federal DEA telehealth flexibilities for controlled substances remain extended through December 31, 2026 (fourth extension). State-level telehealth laws were verified using late-2025 legislative updates and state medical board guidance. Sources reflect 80%+ content published or updated in 2025, with 2024 sources cross-verified for continued accuracy. Readers should monitor the DEA’s pending permanent telehealth rule (expected by end of 2026) and verify any temporary state waivers for changes beyond this publication date.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12